1. Home
  2. RS vs INAB Comparison

RS vs INAB Comparison

Compare RS & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reliance Steel & Aluminum Co. (DE)

RS

Reliance Steel & Aluminum Co. (DE)

HOLD

Current Price

$299.29

Market Cap

15.4B

Sector

Industrials

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.89

Market Cap

22.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RS
INAB
Founded
1939
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4B
22.9M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
RS
INAB
Price
$299.29
$1.89
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$324.33
$6.00
AVG Volume (30 Days)
352.8K
34.5K
Earning Date
05-21-2026
06-23-2026
Dividend Yield
1.68%
N/A
EPS Growth
N/A
N/A
EPS
13.98
N/A
Revenue
$14,805,900,000.00
N/A
Revenue This Year
$8.85
N/A
Revenue Next Year
$1.03
N/A
P/E Ratio
$21.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$250.07
$0.12
52 Week High
$365.59
$4.20

Technical Indicators

Market Signals
Indicator
RS
INAB
Relative Strength Index (RSI) 36.46 54.96
Support Level $283.39 $1.52
Resistance Level $301.60 $2.15
Average True Range (ATR) 8.46 0.16
MACD -1.77 0.05
Stochastic Oscillator 15.66 67.65

Price Performance

Historical Comparison
RS
INAB

About RS Reliance Steel & Aluminum Co. (DE)

Reliance Inc operates a network of companies providing diversified metal solutions and is the metals service center company. It distributes a full line of over 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium and other specialty steel products. The company services more than 125,000 customers in a variety of industries, including consumer products, general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, industrial machinery and heavy industry. It also services the auto industry, through its toll processing operations where it processes customer-owned metal for a fee.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: